Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The American Academy of Neurology Residents as Educators Workgroup Initiative: Nurturing future neurology educators
Education, Research, and Methodology
S34 - Research Methodology and Education (1:48 PM-2:00 PM)
005
Clinical educator tracks have the potential to develop trainees’ teaching skills, improve self-efficacy, and foster interest in medical education. Although such tracks exist in different subspecialties, there is no centralized resource for neurology residents interested in exploring or pursuing a career in medical education. The AAN Resident as Educator Workgroup aims to fill this gap.
To develop a formal training pathway with the American Academy of Neurology (AAN) for neurology trainees interested in pursuing careers in medical education. This track will focus on core educational concepts, fostering the development of direct teaching skills, curriculum development, assessment, mentorship and educational scholarship.
We propose a flexible, longitudinal neurology resident educator track that takes into account the time constraints posed by neurology training. Accepted applicants will have access to educational content in the form of synchronous and asynchronous educational activities. Examples include webinars or live sessions respectively on topics such as clinical teaching, presentation design and delivery, curriculum development, providing feedback, mentorship, educator career development, and education scholarship. Practical activities will include observed lectures, bedside teaching, Problem-Based Learning (PBL) sessions, and morning report. Participants will complete a scholarly project under the guidance of an AAN or local mentor.  A minimum set of activities will need to be completed to graduate from the program. At completion, a certificate will be awarded by the AAN
The AAN Resident as Educators Workgroup will track the graduates’ scholarly activity publications, educational projects and academic career positions. Participants’ satisfaction and feedback about the program will also be collected.
This new AAN initiative will provide neurology trainees with more in-depth knowledge of the skills needed for a successful career in medical education.
Authors/Disclosures
Miguel Chuquilin Arista (Tallahassee Memorial Healthcare)
PRESENTER
Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
Joseph Safdieh (Weill Medical College of Cornell University) Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Marie Eugene (University of Connecticut Health Center) Dr. Eugene has nothing to disclose.
Dara Albert (Nationwide Children's Hospital) Dr. Albert has nothing to disclose.
Erica Schuyler (Hartford HealthCare Ayer Neuroscience Institute) Dr. Schuyler has received personal compensation in the range of $500-$4,999 for serving as a OET Exam Standard Setting with ECFMG/FAIMER. Dr. Schuyler has a non-compensated relationship as a Neurology Review Committee member with ACGME that is relevant to AAN interests or activities.
Igor Rybinnik (Rutgers Robert Wood Johnson Medical School) Dr. Rybinnik has nothing to disclose.
Doris Kung (Baylor College of Medicine) Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Taylor Harrison (Emory University) Dr. Harrison has nothing to disclose.
Suur Biliciler Dr. Biliciler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient CME. Dr. Biliciler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenyx.
Adam Quick (The Ohio State University) The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Erin Furr-Stimming (University of Texas Health Science Center-Houston) Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.